This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Careers
Media
Investors
Contact us

Company

Company

Purpose

Strategy

Leadership

History

Locations

Offering

Offering

Drug Substances

Exclusive synthesis API portfolio Viral vectors

Drug Products

Oral solids Steriles Ophthalmics Inhalation products

Technologies

Sustainability

Sustainability

People

Environment

Integrity

Quality

Community engagement

Risk management

Insights

What are you
looking for?

Company

Purpose

Strategy

Leadership

History

Locations

Offering

Drug Substances

Exclusive synthesis API portfolio Viral vectors

Drug Products

Oral solids Steriles Ophthalmics Inhalation products

Technologies

Sustainability

People

Environment

Integrity

Quality

Community engagement

Risk management

Insights

Careers
Media
Investors
Contact us

Insights

See our event recap

Filter by tags

Technology Sustainability

NEW

07/10/2025

Accelerate drug development with phase-appropriate thinking

Read article

Recent

The power of derivatization: Simple solutions to complex analytical problems

Unlocking the potential of capsule-based dry powder inhalers: From development to commercialization

White label stocking: Enhancing supply chain flexibility and speed to market

Subscribe for more expert insights

All posts

Accelerate drug development with phase-appropriate thinking

Ask better, move faster: Questions that will accelerate the speed of your program to clinical

Oct 30, 2025

Video: Insights from Chief Scientific Officer Stefan Randl at CPHI Frankfurt 2025

Sign up to stay up to date on Siegfried and our business performance.

expect more

Siegfried AG
Untere Brühlstrasse 4
4800 Zofingen, Switzerland

+41 62 746 11 11 info@siegfried.ch

About us

Our company
Sustainability
Media
Investors
Careers

Helpful resources

Expert insights
News archive
Reports
Terms and conditions

Offering

Drug Substances
Drug Products
Technologies

2024 © Siegfried Holding AG